Crossmark Global Holdings, Inc. Haemonetics Corp Transaction History
Crossmark Global Holdings, Inc.
- $5.22 Billion
- Q1 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 7,628 shares of HAE stock, worth $641,743. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,628
Previous 3,626
110.37%
Holding current value
$641,743
Previous $310,000
110.0%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding HAE
# of Institutions
310Shares Held
50.1MCall Options Held
161KPut Options Held
56.3K-
Capital Research Global Investors Los Angeles, CA6.67MShares$562 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.98MShares$503 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$454 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.27MShares$359 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY3.79MShares$319 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.32B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...